Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 1, 2024
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
Colin Langan Maintained (ADNT) at Buy with Decreased Target to $38 on, Apr 1st, 2024
Colin Langan of Wells Fargo, Maintained "Adient plc" (ADNT) at Buy with Decreased Target from $40 to $38 on, Apr 1st, 2024.
Colin has made no other calls on ADNT in the last 4 months.
There are 2 other peers that have a rating on ADNT. Out of the 2 peers that are also analyzing ADNT, 1 agrees with Colin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ryan Brinkman of "JP Morgan" Maintained at Hold with Decreased Target to $40 on, Wednesday, February 28th, 2024
This is the rating of the analyst that currently disagrees with Colin
- Dan Levy of "Barclays" Maintained at Buy with Decreased Target to $41 on, Friday, February 9th, 2024
